Log In
BCIQ
Print this Print this
 

Ovarian cancer vaccine

  Manage Alerts
Collapse Summary General Information
Company MabVax Therapeutics Holdings Inc.
DescriptionVaccine including antigen targeting KLH
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/09/2014

Undisclosed

0

0

Get a free BioCentury trial today